Introduction {#s1}
============

Fetal alcohol spectrum disorder (FASD) is a serious neurodevelopmental disorder that begins in utero, manifests during childhood, and lasts a lifetime. It is caused by prenatal ethanol exposure primarily by maternal gestational alcohol consumption and consists of a collection of conditions including developmental delays, restrictions, abnormalities, as well as intellectual and behavioral impairments ([@B13]). The incidence of FASD varies across different populations, with the estimated prevalence in 7- to 9-year-old Canadians is between 2% and 3% ([@B52]), and between 1% and 5% in the United States ([@B42]). This incidence is expected to increase given a recent Canadian report that alcohol-related emergencies between 2003 and 2016 rose 4.4 times more than overall emergency visits ([@B45]). Specifically, this increase is greater for women (86.5%) than men (53.2%). Among women, 15- to 24-year-olds have the highest rate. Of the medical harms identified, suspected fetal damage including fetal alcohol syndrome rose 2133.3% from 2003 to 2016. As it may extend to other populations, this trend is concerning for more than just Ontario and does not bode well for a focus on FASD prevention *via* alcohol avoidance. The next best strategy is to offer interventions following early diagnosis, which remains problematic given the heterogeneity of manifestation and lack of reliable biomarker. As such, FASD continues to represent a major health and social burden in alcohol-friendly societies.

Given that prenatal alcohol exposure is the cause of FASD, and neurodevelopment is long-lasting, spanning decades, research must also focus on postnatal factors that may determine the manifestation of the disorder. Furthermore, this understanding may offer novel strategies for the remediation of FASD deficits and severity. Molecular brain research in humans is restrictive and must rely on animal models. Our lab has developed a mouse model of FASD using C57BL/6J (B6) mice ([@B28]), establishing that FASD is like an iceberg. Ethanol-exposed pups develop learning deficits, anxiety-like behaviors, and altered activity patterns ([@B3]; [@B25]; [@B28]; [@B40]). What we see as deficit(s) is just the tip---most underlying defects are not visible and are reflected in gene expression alterations ([@B29]).

Mammalian neurodevelopment involves the orchestration of cellular processes that are sensitive to prenatal and postnatal environmental stresses over time ([@B67]). One common postnatal stress that children born with FASD face is maternal separation. Children entering childcare systems, such as foster care or orphanages, represent a particularly vulnerable population, with FASD considerably overrepresented in such individuals ([@B33]). In Canada, the prevalence of FASD is 5 to 67 times higher than a global estimate ([@B34]). In addition to the initial gestational alcohol exposure, exposure to early life stress increases the risk of behavioral deficits, including adult psychiatric disorders ([@B27]). Early life stress has a negative effect on learning and memory processes governed by the hippocampus in rodents ([@B57]; [@B46]; [@B50]). Little is known about how early life stress may affect children born with FASD ([@B54]), although following gestational alcohol exposure and abuse or neglect during early development, children are more likely to have behavioral deficits, including impaired learning and memory ([@B14]; [@B18]; [@B30]; [@B31]).

Since children with FASD often face additional early life stress, we have extended the model to explore how postnatal maternal separation may compound developmental and behavioral deficits following prenatal ethanol exposure ([@B1]). The behaviors affected by prenatal alcohol exposure and maternal separation include anxiety-like behavior as well as learning and memory. While many brain regions may be relevant, the hippocampus forms the focus of this study for its essential role in spatial learning ([@B23]). To this end, we have also reported changes in hippocampal gene expression that persist into adulthood following prenatal ethanol exposure combined with postnatal maternal separation in B6 mice ([@B2]). Given that the initiation and maintenance of aberrant gene expression in response to prenatal ethanol exposure includes epigenetic mechanisms, primarily DNA methylation, noncoding RNA, and histone modifications ([@B11]; [@B35]; [@B10]), these processes are expected to be critical in other models of FASD. In fact, FASD-related human research in epigenetic mechanisms has begun to focus on DNA methylation ([@B36]; [@B53]). While there are many epigenetic mechanisms that may alter transcription, here we focus on promoter DNA methylation that may repress transcription *via* blocked transcription factor binding to explore the canonical relationship between gene expression and promoter DNA methylation ([@B22]).

This research is novel in that it combines the effect of prenatal ethanol exposure and maternal separation on the FASD iceberg using B6 mice at three levels---behavior, hippocampal gene expression and hippocampal DNA methylation on the same samples. Although the behavioral results are compatible with molecular changes, changes in gene expression are rarely related to changes in promoter-specific methylation. It may represent a feature of the experimental design or reflect a general feature of the development of FASD. Although one is tempted to suggest that epigenetic changes other than DNA methylation must represent important underlying mechanisms involved in the development of FASD, the issue deserves further experimentation and comprehensive evaluation. Such clarifications will be needed in the use of these results, including the development of effective measures of remediation.

Materials and Methods {#s2}
=====================

Animals {#s2_1}
-------

C57BL/6J mice originally obtained from Jackson Laboratories (Bar Harbor, ME) were bred and housed in same-sex colonies of up to four individuals with unrestricted food and water access at the Animal Care Facility at Western University (London, Ontario, Canada). Temperature and humidity were maintained at 21°C--24°C and 40%--60%, respectively, with lighting on a 14:10-h light-dark cycle. All housing, bedding, and nest material were consistent between cages. All treatment protocols complied with ethical standards established by the Canadian Council on Animal Care and were approved by the Animal Use Subcommittee at Western University (London, Ontario, Canada).

Continuous Preference Drinking Model {#s2_2}
------------------------------------

Females (10 weeks old) were housed individually and randomly assigned to ethanol or control groups. Both groups had free access to water, with the ethanol group additionally provided free access to 10% ethanol in water solution ([@B28]; [@B1]). Ethanol was introduced with increasing concentrations of 2%, 5%, and 10% after 48 h with the previous concentration. After 10 days of continuous 10% ethanol availability, females were mated with males (15 weeks old) with only water available. Males were removed after a 24-h period and 10% ethanol was returned, which represented gestational day 0. Until postnatal day 10, 10% ethanol was freely available, with only water available for the remainder of this study. Blood alcohol levels were not taken to minimize maternal stress, voluntary consumption of 10% ethanol at 14 g ethanol per kg body weight per day produces peak blood alcohol levels of 120 mg dl^-1^ ([@B3]). This study represents a modest amount of ethanol exposure, with experimental mice consuming 8 g ethanol per kg body weight per day on average, sufficient to produce behavioral deficits in their offspring, including hyperactivity in a novel environment, hypoactivity in a home cage environment, and learning deficits ([@B1]).

Early Life Stress *Via* Maternal Separation and Isolation {#s2_3}
---------------------------------------------------------

Postnatal maternal separation and isolation were used to induce early life stress, as described previously ([@B61]; [@B7]; [@B1]). On postnatal day 2, half of each litter was randomly selected for stress, tail coloring with permanent marker was used to distinguish pups. From postnatal days 2 to 14, stress group pups were removed and isolated for 3 hours per day during the light phase in 8 oz. Dixie cups with bedding and nest material. Pups not selected for maternal separation remained with the dam and other littermates during this time. On postnatal day 21, pups were weaned and housed with same-sex littermates with 2--4 individuals per cage. Following treatments, mice belonged to one of four groups---control, ethanol, stress, or ethanol + stress.

Hippocampal Dissection and DNA Isolation {#s2_4}
----------------------------------------

Male mice were sacrificed *via* carbon dioxide asphyxiation and cervical dislocation on postnatal day 70. The hippocampus was dissected from the whole brain as described previously ([@B63]). With samples stored in phosphate-buffered saline (PBS), snap-frozen in liquid nitrogen, and kept at −80°C. Samples were ground by pestle over liquid nitrogen to create a powder. Stages of buffer RLT (Qiagen, Valencia, CA) were added and mixed by pipetting. Sampled were centrifuged after a 10-min incubation period. The supernatant was loaded onto AllPrep DNA spin columns and the AllPrep DNA/RNA Mini Kit Protocol (Qiagen, Valencia, CA) was followed to isolate DNA and RNA from the same sample. DNA quantification was determined by NanoDrop 2000c Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE).

MeDIP-Seq {#s2_5}
---------

Three DNA samples were randomly selected from each treatment group (12 total DNA samples from individual mice processed separately) and sent on dry ice to Arraystar Inc. (Rockville, MD), with one sample per group as an input sample for sequence control. DNA was quantified by NanoDrop 1000 (Thermo Fisher Scientific, Wilmington, DE), then fragmented to a range of 200--1,500 bp using a Diagenode Bioruptor, end-repaired, and 3\' adenylated for ligation of genomic adapters. Fragments were immunoprecipitated by anti-5-methylcytosine antibody, then PCR amplified. AMPure XP beads were used to select fragments from 300--800 bp, then quantified by Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Following denaturation with 0.1 M NaOH, single-stranded DNA molecules were captured and amplified *in situ* on an Illumina flow cell. Libraries were sequenced on the Illumina HiSeq 4000 platform using the HiSeq 3000/4000 SBS Kit (300 cycles) protocol, then Off-Line Basecaller (OLB V1.8) was used for base calling. Reads were aligned to the mouse genome (UCSC MM10) using HISAT2 (V2.1.0) ([@B26]) after passing the Solexa CHASTITY quality filter and resulting BED files were used for differential methylation analysis. Sequences have been made available at GEO accession number GSE137984.

Differential Methylation Analysis {#s2_6}
---------------------------------

Aligned reads from HISAT2 were used for peak calling using Model-based analysis for ChIP-Seq (MACS) (version 1.4.2) ([@B73]), where enriched regions (peaks) for each sample were identified by comparison to input background samples for each group using a dynamic Poisson distribution (*q* \< 10^-5^). MeDIP enriched regions were annotated to the nearest gene using UCSC RefSeq, with differentially methylated regions (DMRs) in the promoter of known genes for Ethanol vs. Control, Stress vs. Control, as well as Ethanol + stress vs. Control identified by diffReps (cut-off: log~2~FC = 1.0, *p* = 10^-4^) ([@B62]). Promoter regions are defined here as 2,000 bp upstream and downstream from the transcription start site of a gene. Generalized hypergeometric tests for enrichment of gene ontology (GO) terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways were used for genes represented by promoter DMRs for each treatment group using goana and kegga functions in the limma software package ([@B58]) in R, filtered by significance (*p* \< 0.05).

Comparison to Transcriptome Analysis {#s2_7}
------------------------------------

Genes represented by promoter DMRs for each treatment group were compared to previously reported transcript-level expression analysis from an RNA-Seq experiment using RNA isolated from the same samples ([@B2]). Briefly, RNA-Seq was carried out by The Centre for Applied Genomics (The Hospital for Sick Children, Toronto, Ontario, Canada). Paired-end reads were pseudo-aligned to version 38 of the Ensembl mouse transcriptome *via* kallisto ([@B8]) and differential expression analysis was determined using sleuth ([@B51]; [@B71]). Gene lists used here were filtered by significance (*p* \< 0.01), resulting in a list of 164 unique transcripts altered following ethanol exposure, 116 for stress, and 217 for the combination of ethanol + stress. Sequence data for the RNA-Seq experiment is available at the Gene Expression Omnibus (GEO), accession number GSE133369.

Results {#s3}
=======

Hippocampal DNA samples from adult males (postnatal day 70) for each of four groups of mice representing a control group with no experimental interventions, an ethanol group that faced prenatal ethanol exposure, a stress group that faced postnatal maternal separation stress, and an ethanol + stress group subject to both treatments (see methods for specific details). DNA methylation profiles were assessed *via* MeDIP-Seq to determine how treatment groups differ from controls.

DNA Methylation Changes Following Different Treatments {#s3_1}
------------------------------------------------------

DMRs (DMRs) were determined for each experimental treatment group compared to controls, then associated with annotated genes *via* proximity to transcription start sites. Promoter regions are defined here as 2 kb upstream or downstream from the transcription start site of a gene, with genes with promoter DMRs considered for this analysis. In this way, several DMRs considered spatially distinct can be present in the promoter region of a single or multiple gene(s). A gene implicated by more than one DMR is considered separately when the DMRs are in opposition, but only once if the DMRs are in the same direction. Using promoter DMRs, 1,264 genes are implicated by prenatal ethanol treatment ([**Figure 1A**](#f1){ref-type="fig"}, details in [**Supplementary Table 1**](#SM1){ref-type="supplementary-material"}). Following postnatal maternal separation stress, 1,472 genes are represented by promoter DMRs ([**Figure 1B**](#f1){ref-type="fig"}, details in [**Supplementary Table 2**](#SM2){ref-type="supplementary-material"}). When mice faced both ethanol + stress, 958 genes are implicated by promoter DMRs ([**Figure 1C**](#f1){ref-type="fig"}, details in [**Supplementary Table 3**](#SM3){ref-type="supplementary-material"}). Interestingly, while the ethanol group has a similar number of genes implicated by hypo- and hypermethylated promoter DMRs, the stress group genes are represented by 73% hypomethylated promoter DMRs. Genes implicated by promoter DMRs in the ethanol + stress group are also more evenly distributed between hypo- and hypermethylated. While a single DMR is either hypo- or hypermethylated, a single gene may be represented by multiple DMRs with different states. There are between 16 and 29 genes in each comparison that are implicated by both hypo- and hypermethylation of promoter DMRs.

![The number of genes with significant (*p* \< 0.01) promoter DNA methylation changes following **(A)** prenatal ethanol treatment, **(B)** early life stress treatment, or **(C)** the combination of prenatal ethanol treatment and early life stress as compared to controls.](fgene-11-00070-g001){#f1}

Hypo- and hypermethylated DMR-associated genes for each treatment group were analyzed separately for GO and KEGG pathway enrichment. In the ethanol group, genes related to voltage-gated calcium channel activity tended to be hypomethylated at their promoter regions (*p* \< 0.007) ([**Table 1**](#T1){ref-type="table"}). In addition, brain-related terms including NMDA receptor activity (*p* = 0.001), positive regulation of behavior (*p* = 0.002), circadian rhythm (*p* = 0.003), and apical dendrite (*p* = 0.03) were all biological processes overrepresented by genes with hypomethylated promoters following ethanol exposure. Interestingly, components responsible for transcriptional regulation are also implicated by genes with hypomethylated promoters, including PRC1 complex (*p* = 4.04 x 10^-4^), transcription factor TFIID complex (*p* = 0.03), and RNA polymerase II transcription factor complex (*p* = 0.046). Genes related to phosphoinositide kinase (*p* \< 0.02) and cytoskeleton regulation (*p* = 0.005) were hypermethylated at their promoter regions following prenatal ethanol exposure. In the stress group, genes important for histone modifications (*p* \< 0.01) and neuronal organization (*p* = 0.007) were overrepresented by genes with hypomethylated promoters ([**Table 2**](#T2){ref-type="table"}). Conversely, genes with hypermethylated promoters following stress are important for cytokine interactions (*p* \< 0.006). When mice faced both ethanol + stress, genes important for neuron migration (*p* \< 0.005) were hypomethylated at their promoters ([**Table 3**](#T3){ref-type="table"}). As with stress alone, the combination of ethanol + stress results in promoter hypermethylation for genes responsible for cytokine interactions (*p* \< 0.01).

###### 

Top five most significantly (*p* \< 0.05) overrepresented gene ontology (GO) terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways represented by either hypo- or hypermethylated differentially methylated region (DMR)-associated genes implicated by Ethanol treatment compared to control (*p* \< 0.01).

  Hypomethylated                                           p-value    Hypermethylated                                           p-value
  -------------------------------------------------------- ---------- --------------------------------------------------------- ---------
  **Molecular function**                                                                                                        
  hydrolase activity, hydrolyzing O-glycosyl compounds     0.001      phosphatidylinositol bisphosphate kinase activity         0.001
  voltage-gated cation channel activity                    0.005      phosphatidylinositol-4,5-bisphosphate 3-kinase activity   0.002
  voltage-gated calcium channel activity                   0.007      phosphatidylinositol 3-kinase activity                    0.003
  high voltage-gated calcium channel activity              0.007      1-phosphatidylinositol-3-kinase activity                  0.014
  protein tyrosine kinase activity                         0.008      C3HC4-type RING finger domain binding                     0.015
  **Biological process**                                                                                                        
  regulation of cation channel activity                    8.71E-05   regulation of transport                                   0.004
  regulation of NMDA receptor activity                     0.001      photoreceptor cell development                            0.005
  positive regulation of behavior                          0.002      eye photoreceptor cell development                        0.006
  regulation of skeletal muscle cell differentiation       0.002      lymphocyte differentiation                                0.010
  positive regulation of circadian rhythm                  0.003      anion transport                                           0.010
  **Cellular component**                                                                                                        
  PRC1 complex                                             4.04E-04   unconventional myosin complex                             0.026
  apical dendrite                                          0.025      proton-transporting V-type ATPase complex                 0.048
  transcription factor TFIID complex                       0.026                                                                
  nuclear ubiquitin ligase complex                         0.043                                                                
  RNA polymerase II transcription factor complex           0.046                                                                
  **KEGG pathway**                                                                                                              
  PPAR signaling pathway                                   0.018      Carbohydrate digestion and absorption                     0.003
  Hypertrophic cardiomyopathy (HCM)                        0.019      Regulation of actin cytoskeleton                          0.005
  Fructose and mannose metabolism                          0.024      Pyrimidine metabolism                                     0.011
  Arrhythmogenic right ventricular cardiomyopathy (ARVC)   0.027      Focal adhesion                                            0.013
  Glycosaminoglycan degradation                            0.028      Glyoxylate and dicarboxylate metabolism                   0.017

###### 

Top five most significantly (*p* \< 0.05) overrepresented gene ontology (GO) terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways represented by either hypo- or hypermethylated differentially methylated region (DMR)-associated genes implicated by Stress treatment compared to control (*p* \< 0.01).

  Hypomethylated                                                   p-value   Hypermethylated                                                                                               p-value
  ---------------------------------------------------------------- --------- ------------------------------------------------------------------------------------------------------------- ----------
  **Molecular function**                                                                                                                                                                   
  SUMO-specific protease activity                                  0.005     voltage-gated potassium channel activity in ventricular cardiac muscle cell action potential repolarization   4.96E-04
  protein-arginine omega-N asymmetric methyltransferase activity   0.007     voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization      0.002
  nonmembrane spanning protein tyrosine kinase activity            0.009     oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor                           0.004
  histone-arginine N-methyltransferase activity                    0.010     cytokine activity                                                                                             0.006
  arginine N-methyltransferase activity                            0.014     peptidyl-proline 4-dioxygenase activity                                                                       0.006
  **Biological process**                                                                                                                                                                   
  histone methylation                                              0.003     positive regulation of protein secretion                                                                      3.88E-04
  smooth muscle contraction                                        0.005     regulation of macrophage cytokine production                                                                  0.001
  apoptotic nuclear changes                                        0.007     ventricular cardiac muscle cell membrane repolarization                                                       0.001
  regulation of microtubule cytoskeleton organization              0.007     positive regulation of cytokine secretion                                                                     0.001
  neuron projection extension in neuron projection guidance        0.007     cardiac muscle cell membrane repolarization                                                                   0.001
  **Cellular component**                                                                                                                                                                   
  multivesicular body membrane                                     0.005     multivesicular body                                                                                           0.025
  T cell receptor complex                                          0.009     T cell receptor complex                                                                                       0.045
  actin cytoskeleton                                               0.017     platelet alpha granule                                                                                        0.045
  multivesicular body                                              0.021                                                                                                                   
  cytoplasmic stress granule                                       0.024                                                                                                                   
  **KEGG pathway**                                                                                                                                                                         
  Chemokine signaling pathway                                      0.020     Cytokine-cytokine receptor interaction                                                                        1.34E-06
                                                                             Neuroactive ligand-receptor interaction                                                                       0.008
                                                                             Antigen processing and presentation                                                                           0.013
                                                                             TGF-beta signaling pathway                                                                                    0.013
                                                                             Hematopoietic cell lineage                                                                                    0.015

###### 

Top five most significantly (*p* \< 0.05) overrepresented gene ontology (GO) terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways represented by either hypo- or hypermethylated differentially methylated region (DMR)-associated genes implicated by combined Ethanol + Stress treatments compared to control (*p* \< 0.01).

  Hypomethylated                                            p-value    Hypermethylated                                           p-value
  --------------------------------------------------------- ---------- --------------------------------------------------------- ----------
  **Molecular function**                                                                                                         
  acetylglucosaminyltransferase activity                    0.001      anion transmembrane transporter activity                  0.005
  Rho guanyl-nucleotide exchange factor activity            0.014      inorganic anion transmembrane transporter activity        0.008
  ether hydrolase activity                                  0.014      organic anion transmembrane transporter activity          0.009
  phosphofructokinase activity                              0.014      cytokine receptor activity                                0.011
  transmembrane receptor protein tyrosine kinase activity   0.015      extracellular ATP-gated cation channel activity           0.012
  **Biological process**                                                                                                         
  mRNA polyadenylation                                      4.50E-04   positive regulation of calcium-mediated signaling         0.006
  RNA polyadenylation                                       0.001      monocarboxylic acid metabolic process                     0.006
  regulation of neuron migration                            0.001      sphingosine-1-phosphate signaling pathway                 0.009
  positive regulation of neuron migration                   0.002      amylin receptor signaling pathway                         0.009
  neuron projection extension                               0.005      response to insulin                                       0.009
  **Cellular component**                                                                                                         
  L-type voltage-gated calcium channel complex              0.011      integral component of nuclear inner membrane              0.003
  azurophil granule membrane                                0.013      extrinsic component of external side of plasma membrane   0.012
                                                                       G-protein coupled receptor dimeric complex                0.020
                                                                       brush border membrane                                     0.035
  **KEGG pathway**                                                                                                               
                                                                       Cytokine-cytokine receptor interaction                    1.68E-05
                                                                       Hematopoietic cell lineage                                0.001
                                                                       Mucin type O-glycan biosynthesis                          0.001
                                                                       JAK-STAT signaling pathway                                0.003
                                                                       Dilated cardiomyopathy (DCM)                              0.026

DNA Methylation Patterns Are Shared by Different Treatments {#s3_2}
-----------------------------------------------------------

While genes implicated by promoter DMRs are unique to each treatment, there are regions of overlap between treatments ([**Figure 2**](#f2){ref-type="fig"}). 120 genes are implicated by promoter DMRs following ethanol, stress, as well as ethanol + stress ([**Figure 2A**](#f2){ref-type="fig"}). When directionality is considered, there are 85 genes implicated by hypomethylated promoter DMRs in all three treatment groups ([**Figure 2B**](#f2){ref-type="fig"}). Finally, there are 19 genes implicated by hypermethylated promoter DMRs in all three treatment groups ([**Figure 2C**](#f2){ref-type="fig"}). Genes consistently implicated by promoter DMR hypomethylation tend to be important for histone methylation (*p* \< 0.04) and cyclic adenosine monophosphate (cAMP) protein kinase activity (*p* \< 0.04) ([**Table 4**](#T4){ref-type="table"}). Conversely, genes implicated by promoter DMR hypermethylation are important for ion channel activity (*p* \< 0.007) as well as neuroactive ligand-receptor interactions (*p* = 0.04) and chemokine signaling (*p* \< 0.003).

![The number of genes with significant promoter DNA methylation changes shared following prenatal ethanol treatment, early life stress, or the combination of ethanol + stress with **(A)** all genes grouped together, **(B)** genes with hypomethylated promoters grouped together, and **(C)** genes with hypermethylated promoters grouped together.](fgene-11-00070-g002){#f2}

###### 

Top five most significantly (*p* \< 0.05) overrepresented gene ontology (GO) terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways represented by either hypo- or hypermethylated differentially methylated region (DMR)-associated genes implicated by all three treatment categories---Ethanol, Stress, and combined Ethanol + Stress compared to control (*p* \< 0.01).

  Hypomethylated                                                             p-value   Hypermethylated                                   p-value
  -------------------------------------------------------------------------- --------- ------------------------------------------------- ---------
  **Molecular function**                                                                                                                 
  cAMP-dependent protein kinase regulator activity                           0.029     ATP-gated ion channel activity                    0.007
  protein-arginine omega-N asymmetric methyltransferase activity             0.034     extracellular ATP-gated cation channel activity   0.007
  histone-arginine N-methyltransferase activity                              0.038     nucleotide receptor activity                      0.007
  cAMP-dependent protein kinase inhibitor activity                           0.038     purinergic receptor activity                      0.008
  arginine N-methyltransferase activity                                      0.042     mannose binding                                   0.010
  **Biological process**                                                                                                                 
  endosome to lysosome transport *via* multivesicular body sorting pathway   0.025     mesodermal cell fate commitment                   0.006
  phagosome-lysosome fusion                                                  0.025     bone resorption                                   0.008
  choline catabolic process                                                  0.025     neuromuscular process controlling balance         0.013
  regulation of protein metabolic process                                    0.027     neuromuscular process                             0.015
  regulation of high voltage-gated calcium channel activity                  0.029     response to interferon-alpha                      0.016
  **Cellular component**                                                                                                                 
  L-type voltage-gated calcium channel complex                               0.029     integral component of nuclear inner membrane      0.011
  perinuclear endoplasmic reticulum                                          0.034     multivesicular body                               0.028
  **KEGG pathway**                                                                                                                       
                                                                                       Chemokine signaling pathway                       0.001
                                                                                       Cytokine-cytokine receptor interaction            0.003
                                                                                       Neuroactive ligand-receptor interaction           0.042

DNA Methylation Alterations in Relation to Gene Expression {#s3_3}
----------------------------------------------------------

Since hippocampal transcriptome profiles exist for these mice, genes implicated by altered promoter methylation could be compared to genes with altered transcription. The number of genes represented by altered promoter methylation following each treatment is represented by the direction of transcriptional change following the RNA-Seq study previously reported are presented here ([**Table 5**](#T5){ref-type="table"}). While many genes are included for comparison, the overlap between genes implicated by altered DNA methylation and transcription is minimal. For ethanol mice, 1,264 genes with promoter DMRs were compared to the previously reported 164 unique transcripts altered in these samples. There are two corresponding transcripts with hypomethylated promoters and increased expression, *Slc2a9*, solute carrier family 2 (facilitated glucose transporter), member 9, and *Blvrb*, biliverdin reductase B (flavin reductase (NADPH)). Conversely, for hypermethylated promoters, there are two transcripts with decreased expression following PAE, *Eif4g1*, eukaryotic translation initiation factor 4, gamma 1, and *Myo6*, myosin VI.

###### 

Relevant genes through the complementary direction, increase (↑) or decrease (↓) of methylation and gene expression changes compared to control for genes differentially expressed with promoter differentially methylated regions (DMRs).

  -------------------------------------------------------------------------------------------------------------
             Direction               Methylation   Expression                                           
  ---------- ----------- ---- ------ ------------- --------------------------- ------- ------- -------- -------
                                     *Slc2a9*      chr5:38481041-38481660      −1.80   0.006   2.576    0.005

                         ↑    2                                                                         

             ↓                       *Blvrb*       chr5:38481041-38481660      −1.80   0.006   2.576    0.005

                         ↓    0      --            --                          --      --      --       --

                         --   632    --            --                          --      --      --       --

  Ethanol                                                                                               

                                     *Eif4g1*      chr16:20671221-20671520     inf     0.003   −3.487   0.008

                         ↓    2                                                                         

             ↑                       *Myo6*        chr9:80164241-80164600      3.03    0.009   −3.625   0.001

                         ↑    0      --            --                          --      --      --       --

                         --   648    --            --                          --      --      --       --

                                     Arpp21        chr9:112234421-112234980    −3.79   0.002   2.253    0.006

                         ↑    3      *Mark2*       chr19:7340121-7341000       −2.03   0.001   3.413    0.003

             ↓                       Rab33b        chr3:51485781-51486080      -inf    0.003   2.830    0.009

  Stress                 ↓    2      --            --                          --      --      --       --

                         --   1070   --            --                          --      --      --       --

                         ↓    1      *Slc39a11*    chr11:113567341-113567720   3.33    0.010   −2.768   0.009

             ↑           ↑    0      --            --                          --      --      --       --

                         --   425    --            --                          --      --      --       --

                                     *Arpp21*      chr9:112184321-112185360    −1.05   0.006   2.663    0.001

                         ↑    3      *Dlg3*        chrX:100773301-100773560    -inf    0.009   3.123    0.001

             ↓                       *Pinx1*       chr14:63859301-63859580     -inf    0.007   0.439    0.005

                         ↓    2      --            --                          --      --      --       --

  Ethanol\               --   467    --            --                          --      --      --       --
  + Stress                                                                                              

                                     *Slu7*        chr11:43434381-43434620     inf     0.004   −0.459   0.007

                         ↓    2                                                                         

             ↑                       *Unc119*      chr11:78341401-78341900     1.90    0.006   −3.900   0.004

                         ↑    1      --            --                          --      --      --       --

                         --   499    --            --                          --      --      --       --
  -------------------------------------------------------------------------------------------------------------

-- Indicates data is not applicable or not provided for clarity.

In the stress group, 1,472 genes with promoter DMRs were compared to the 116 unique transcripts altered in these samples. There are three genes with hypomethylated promoters and increased transcript expression, *Arpp21*, cyclic AMP-regulated phosphoprotein, 21, *Mark2*, microtubule affinity regulating kinase 2, and *Rab33b*, RAB33B, member RAS oncogene family. One gene, *Slc39a11*, solute carrier family 39 (metal ion transporter), member 11, is hypermethylated at its promoter and has reduced transcript expression following maternal separation.

For ethanol + stress mice, 958 genes with promoter DMRs were compared to the 217 unique transcripts altered in these samples. Interestingly, *Arpp21* is also hypomethylated at its promoter and overexpressed following ethanol + stress treatment alongside two additional genes, *Dlg3*, discs large MAGUK scaffold protein 3, and *Pinx1*, PIN2/TERF1 interacting, telomerase inhibitor 1. Conversely, two genes share increased promoter methylation and decreased gene expression, *Slu7*, pre-mRNA-splicing factor SLU7, and *Unc119*, unc-119 lipid binding chaperone. While the number of genes with altered promoter methylation and expression resulting from each treatment or combination of treatments is minimal, most of these genes have known brain functions in the literature, ranging from neuronal migration to synapse formation and plasticity ([**Table 6**](#T6){ref-type="table"}).

###### 

Genes of interest identified by altered promoter methylation and gene expression with literature-based evidence of central nervous system function.

  ----------------------------------------------------------------
  Gene of\   Central nervous system relevance
  interest   
  ---------- -----------------------------------------------------
  *Slc2a9*   Memory performance ([@B20])\
             Social phobia ([@B39])

  *Eif4g1*   Neurodegeneration ([@B17])

  *Myo6*     Dendritic spine length ([@B5])\
             Postsynaptic receptor internalization ([@B47])\
             Presynaptic glutamate release potentiation ([@B70])

  *Arpp21*   Dendrite growth ([@B56])

  *Mark2*    Neuron migration ([@B60]; [@B44])

  *Rab33b*   Axon growth ([@B21])

  *Dlg3*     Synapse formation, spatial learning ([@B16])\
             Intellectual disability ([@B66])

  *Pinx1*    Late-onset Alzheimer disease ([@B68])

  *Unc119*   Dendritic branching ([@B41])
  ----------------------------------------------------------------

Discussion {#s4}
==========

FASD is a prevalent societal burden that has remained complex to understand. Children born with FASD are often exposed to stressful postnatal environments that include maternal separation. Our main objective was to understand how early life stresses may complicate molecular changes underlying behavioral deficits that arise following prenatal ethanol exposure. Previously, behavioral changes resulting from prenatal ethanol exposure and postnatal maternal separation stress have been characterized ([@B1]), with lasting changes to the hippocampal transcriptome also being reported ([@B2]). Here we focus on alterations to promoter DNA methylation in the same mice. The behavioral deficits originally reported were subtle in nature, a direct result of the subtlety of the treatment paradigms used. In addition, gene expression alterations were small in fold change, detected at postnatal day 70, long after the final experimental interventions.

Ethanol-Induced Alterations in DNA Methylation {#s4_1}
----------------------------------------------

Prenatal ethanol exposure results in specific changes in promoter DNA methylation. We report promoter hypomethylation of genes important for brain function and formation as well as for transcriptional regulation following prenatal ethanol exposure. We also found promoter hypermethylation of genes important for phosphoinositide kinase activity as well as cytoskeleton regulation. These alterations may be lasting evidence of altered control of gene expression earlier during development that persists into adulthood. The ethanol exposure model employed here has been used previously, with lasting alterations to whole-brain DNA methylation profiles ([@B35]). While we report comparable amounts of hypo- and hypermethylated gene promoters following continuous gestational ethanol exposure, previous work using targeted binge exposure trimester three equivalent models have found alcohol-induced hypermethylation in the hippocampus in both mice ([@B10]) and rats ([@B48]). Conversely, a model of ethanol exposure more representative of trimester two equivalent exposure in mice found global hypomethylation in the neocortex, but this pattern is more complex when brain structures are independently assessed ([@B49]). Our work uses a continuous exposure model and is aimed at investigating promoter methylation, highlighting the importance of dose and timing of ethanol exposure as well as specific methylation patterns being observed.

Maternal Separation-Induced Alterations in DNA Methylation {#s4_2}
----------------------------------------------------------

We report more genes with hypo- than hypermethylated promoters following early life stress *via* maternal separation. Of these, hypomethylated genes tend to be important for histone methylation and chemokine activity. Meanwhile, hypermethylated promoters tend to be of genes important for cytokine interactions. Early life stress results in lasting changes to DNA methylation in the hippocampus of rats ([@B32]). In humans, child abuse has been associated with hypermethylation of several genomic loci in the hippocampus ([@B43]). Meanwhile, maternal separation in rats induces an inflammatory immune response in the hippocampus ([@B59]). Interestingly, early life stress has been associated with reduced serum cytokine levels, suggesting that hypermethylation of related genes may not be hippocampal specific, rather playing a more ubiquitous role in the body ([@B55]).

Ethanol + Maternal Separation-Induced Alterations in DNA Methylation {#s4_3}
--------------------------------------------------------------------

The combination of prenatal ethanol exposure and maternal separation stress resulted in the hypomethylation of genes important for neuronal migration and hypermethylation of genes related to cytokine interactions. Similarly, genes that were implicated by hypermethylated promoters following any of the treatments were also important for chemokine and cytokine interactions. It is apparent from [**Figure 1**](#f1){ref-type="fig"} that the addition of early life stress to individuals that faced prenatal ethanol exposure does not result in an additive DNA methylation response. Few genes are shared between ethanol only or stress only and the combination of treatments as implicated by promoter DMRs. Prenatal ethanol exposure followed by early life stress has been associated with altered immune system development, with early life adversity differentially affecting peripheral and central immune response depending on previous ethanol exposure ([@B55]).

Overlaps Between DNA Methylation and Gene Expression Changes Are Scarce {#s4_4}
-----------------------------------------------------------------------

We previously reported changes in gene expression in association with behavioral deficits following prenatal ethanol exposure and maternal separation in these mice ([@B2]). Interestingly the module of genes most closely associated with treatment and anxiety-like behavior includes genes important for transcriptional regulation and neurodevelopment. With these results in mind, we examined what overlap exists between genes with altered expression and altered promoter methylation that is complementary.

Following prenatal ethanol exposure, two genes have decreased promoter methylation and corresponding increased expression---*Slc2a9* and *Blvrb*. *Slc2a9* codes for a fructose transporter that acts as a uric acid transporter ([@B37]). While not much is known regarding its role in the brain, SLC2A9 SNPs have been associated with better memory performance ([@B20]), and social phobia ([@B39]). *Blvrb* codes for an oxidoreductase important for heme degradation, with no clear link to brain function. Prenatal ethanol exposure results in promoter hypermethylation and decreased transcript expression for two genes, *Eif4g1* and *Myo6*. *Eif4g1* produces a translation initiation factor, eIF4G, with mutations present in familial Parkinson Disease ([@B9]). In fact, this gene acts as a scaffold protein with others in the hippocampus in ways that are perturbed in neurodegeneration likely through protein misfolding ([@B17]). *Myo6* is an actin-based motor protein that has been previously linked to stress response in the mouse hippocampus ([@B65]). Mice lacking this gene have fewer synapses and shorter dendritic spines ([@B5]). *Myo6* is important for postsynaptic stimulus-dependent α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-type glutamate receptor (AMPAR) internalization ([@B47]), as well as for brain-derived neurotrophic factor (BDNF)-mediated glutamate release from presynaptic terminals in long-term potentiation ([@B70]). Together, these results suggest the combined accumulation of DNA methylation, followed by reduced expression of these transcripts may be important for the altered brain-related phenotypes observed in these mice following prenatal ethanol exposure.

There are three genes with promoter hypomethylation and a corresponding increase in transcript expression following maternal separation stress, *Arpp21*, *Mark2*, and *Rab33b*. *Arpp21* is also implicated by the combination of ethanol + stress through promoter hypomethylation and increased expression. The ARPP21 protein product is composed of conserved domains for RNA-binding, with the ability to interact with eIF4G and preferentially bind to the 3\' untranslated regions of mRNAs. Additionally, overexpression and knockdown experiments of ARPP21 show it positively regulates dendrite growth ([@B56]). While we report increased *Arpp21* expression following stress or ethanol + stress, stress-induced decreases have also been reported ([@B15]). *Mark2* produces a serine/threonine-protein kinase involved in cell polarity and microtubule dynamics, as well as in neuron migration ([@B60]; [@B44]). *Rab33b* is a member of Rab family proteins that regulate intracellular vesicular trafficking, particularly at the Golgi apparatus ([@B75]). Recently, the zebrafish ortholog of *Rab33b*, *rab33ba*, has been shown to mediate axon outgrowth in the forebrain ([@B21]). *Slc39a11* is the only gene that has promoter hypermethylation and overexpression in the stress group. It codes for a Zrt-, Irt-like protein (ZIP) for zinc transport ([@B72]). Taken together, these results suggest that the loss of methylation and subsequent overexpression of these genes following postnatal maternal separation stress may lead to observed changes in behavioral phenotypes mediated by improper neuronal migration and growth.

The combination of ethanol + stress treatments results in three genes with increased expression and corresponding promoter hypomethylation, *Arpp21*, *Dlg3*, and *Pinx1*. *Arpp21* was introduced previously as it was also implicated by stress alone. Of these, *Dlg3* is one of the most significantly altered transcripts in response to Stress and Ethanol + Stress treatments that we previously reported ([@B2]). It codes for synapse-associated protein 102, a protein important for synapse formation. Knockout mice have impaired synaptic plasticity and spatial learning ([@B16]), while human *DLG3* mutations result in nonsyndromic X-linked intellectual disability ([@B66]). *Pinx1* is a telomerase inhibitor with little known brain function, although variants have been associated with late-onset Alzheimer disease ([@B68]). Two genes share decreased promoter methylation and increased expression following the combination of treatments, *Slu7* and *Unc119*. *Slu7* is a pre-mRNA splicing factor that forms part of the spliceosome and is important for genome stability ([@B24]). *Unc119* codes for a lipid binding chaperone required for G protein localization in sensory neurons ([@B74]). In fact, knockdown of *Unc119* results in neurotoxicity and decreased dendritic branching ([@B41]). These results suggest that dysregulation of genes important for neuronal migration and synapse formation as well as genome integrity *via* altered promoter methylation following the combination of ethanol + stress may underlie the complex and heterogeneous behavioral changes observed in these mice.

Beyond Promoter DNA Methylation {#s4_5}
-------------------------------

Promoter DNA methylation is an essential mechanism of epigenetic control for the expression of genes. It is affected by environmental factors, including ethanol and stress. Changes in promoter DNA methylation status can lead to the initiation and maintenance of gene expression over time. Promoter DNA methylation has been the research focus in FASD, however, DNA methylation does not act in isolation. While we focus on DMRs in gene promoters, methylation status at a single CpG site may be sufficient to influence gene expression. In this analysis, we may miss the influence of a single CpG that has this type of influence without resulting in a significantly altered region of DNA methylation. Similarly, we have focused on promoter DNA methylation for its known influence on gene expression *via* altered transcription factor binding. Gene body or other intergenic changes in methylation would not be captured in this analysis and may be important for gene expression. Phenotypic outcomes are often the result of interrelated epigenetic mechanisms. For example, noncoding RNAs are also important for the regulation of gene expression at the transcriptional and posttranscriptional levels. They include long noncoding RNAs (lncRNAs) ([@B38]), microRNAs (miRNAs) ([@B12]), short interfering RNAs (siRNAs), and piwi-interacting RNAs (piRNAs) ([@B19]). In FASD research, the noncoding RNA research has been focused on the relationship between microRNAs and their mRNA gene targets. Several microRNAs are altered in reciprocal direction to their gene targets following prenatal alcohol exposure ([@B6]; [@B35]), offering another potential avenue for control. Additionally, modifications to histone tails at specific genomic loci are the foundation of epigenetic mechanisms, with a wide variety of known potential modifications ([@B4]). In FASD mouse models, altered histone modifications ([@B69]; [@B10]), as well as enhanced lysine dimethyltransferase activity resulting in increased histone H3 lysine 9 and 27 dimethylation and neurodegeneration have been reported ([@B64]). Such results suggest changes in gene-specific expression in response to prenatal ethanol exposure must be the result of a variety of epigenetic mechanisms. Although DNA methylation, noncoding RNAs, and histone modifications have all been implicated, their inter-relationship is not known.

The promoter DNA methylation results included in this report are novel in that they were obtained from the same mice that were used to assess behavioral changes ([@B1]) and hippocampal gene expression ([@B2]). This allows for assessment of the relationship between promoter DNA methylation and expression of that gene in response to prenatal ethanol exposure, postnatal maternal separation, and the combination of both treatments. Our results implicate many genes *via* altered expression or promoter DNA methylation, and these genes are relevant in the context of their involvement in ethanol or stress response. In fact, many genes implicated are important for brain development and function. What is apparent is that changes in expression of only a small subset of genes is compatible with changes in promoter DNA methylation. The results argue that promoter methylation is only partly involved in the environmentally induced changes in gene expression we have modeled. Epigenetic mechanisms other than promoter DNA methylation therefore are likely responsible for the lasting gene expression alterations and behavioral abnormalities seen in pups subjected to prenatal ethanol exposure, maternal separation, and the combination of the two treatments. Although logical, such conclusions must be assessed experimentally, as the hippocampus represents a heterogenous cell population. Also, the interventions used are relatively mild, applied during neurodevelopment, with methylation status assessed in adulthood. Not surprisingly, this experimental paradigm has resulted in subtle changes in both gene expression and DNA methylation. Future research must focus on experimentally establishing mechanisms involved in altered gene expression and maintenance of these changes in different cell types within the brain. This will require modified experimental protocols and the use of single cell sequencing. Greater understanding into how these changes occur and persist has the potential to lead to the development of novel strategies for the amelioration of FASD-related deficits for children born with this common and complex disorder.
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Hypo- and hypermethylated promoter DMRs from adult hippocampus following prenatal ethanol exposure compared to untreated controls filtered by significance (*p* \< 0.01).
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Hypo- and hypermethylated promoter DMRs from adult hippocampus following postnatal maternal separation stress treatment compared to controls filtered by significance (*p* \< 0.01).
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Hypo- and hypermethylated promoter DMRs from adult hippocampus following prenatal alcohol exposure and postnatal maternal separation stress as compared to controls, filtered by significance (*p* \< 0.01).
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